Posted by Michael Wonder on 05 Nov 2020
EMA will assess potential COVID-19 vaccine on ‘case by case’ basis
5 November 2020 - Agency will not specify a minimum level of efficacy.
The EMA has said it will not set a minimum level of efficacy for potential COVID-19 vaccines, instead opting to assess vaccines on a ‘case by case’ basis, according to Reuters.
